Publications - IR Sant Pau

Search

01/01/2023 High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion

Caballero A.C., Escribà-Garcia L., Pujol-Fernández P., Escudero-López E., Ujaldón-Miró C., Montserrat-Torres R., Sierra J., Alvarez-Fernández C., Briones J.. High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion. CANCER GENE THERAPY. 2023; 30(1)DOI:10.1038/s41417-022-00518-6. PMID:36031661. IF:4.800(Q1/2D).

01/01/2023 Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope

Del Principe, MI, Seidel, D, Criscuolo, M, Dargenio, M, Racil, Z, Piedimonte, M, Marchesi, F, Nadali, G, Koehler, P, Fracchiolla, N, Cattaneo, C, Klimko, N, Spolzino, A, Karapinar, DY, Demiraslan, H, Duarte, RF, Demeter, J, Stanzani, M, Melillo, LMA, Basilico, CM, Cesaro, S, Paterno, G, Califano, C, Delia, M, Buzzatti, E, Busca, A, Cornely, OA, Pagano, L, Alakel, N, Arsenijevi'c, VA, Camus, V, Falces-Romero, I, Itzhak, L, Kouba, M, Martino, R, Sedlacek, P, Weinbergerova, B. Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope. MYCOSES. 2023; 66(1)DOI:10.1111/myc.13524. PMID:36064299. IF:4.100(Q1/2D).

01/01/2023 Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols

Barba, P, Morgades, M, Montesinos, P, Gonzalez-Campos, J, Torrent, A, Gil, C, Bernal, T, Tormo, M, Mercadal, S, Novoa, S, Garcia-Cadenas, I, de Llano, MPQ, Cervera, M, Coll, R, Bermudez, A, Amigo, ML, Monsalvo, S, Esteve, J, Garcia-Boyero, R, Novo, A, Rivas, JMH, Cladera, A, Martinez-Sanchez, P, Serrano, J, Artola, MT, Soria, B, Abella, E, Vall-Llovera, F, Bergua, J, Herrera, P, Barrios, D, Ribera, JM. Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols. Hemasphere. 2023; 7(1)DOI:10.1097/HS9.0000000000000810. PMID:36583094. IF:11.900(Q1/1D).

01/01/2023 High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion (vol 30, pg 51, 2023)

Caballero A.C., Escribà-Garcia L., Pujol-Fernández P., Escudero-López E., Ujaldón-Miró C., Montserrat-Torres R., Sierra J., Alvarez-Fernández C., Briones J.. High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion (vol 30, pg 51, 2023). CANCER GENE THERAPY. 2023; 30(1)DOI:10.1038/s41417-022-00564-0. PMID:36460806. IF:4.800(Q1/2D).

01/01/2023 LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors

Cruz D., Rodríguez-Romanos R., González-Bartulos M., García-Cadenas I., de la Cámara R., Heras I., Buño I., Santos N., Lloveras N., Velarde P., Tuset E., Martínez C., González M., Sanz G.F., Ferrá C., Sampol A., Coll R., Pérez-Simón J.A., López-Jiménez J., Jurado M., Gallardo D.. LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1066393. PMID:36742309. IF:5.700(Q1/3D).

01/01/2023 Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma

Kwon M., Iacoboni G., Reguera J.L., López Corral L., Morales R.H., Ortiz-Maldonado V., Guerreiro M., Caballero A.C., Domínguez M.L.G., Pina J.M.S., Mussetti A., Sancho J.M., Bastos-Oreiro M., Catala E., Delgado J., Henriquez H.L., Sanz J., Calbacho M., Bailén R., Carpio C., Ribera J.M., Sureda A., Briones J., Hernandez-Boluda J.C., Cebrián N.M., Martin J.L.D., Martín A., Barba P.. Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma. HAEMATOLOGICA. 2023; 108(1)DOI:10.3324/haematol.2022.280805. PMID:35770532. IF:10.100(Q1/2D).

01/01/2023 A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development

Dickinson M.J., Barba P., Jäger U., Shah N.N., Blaise D., Briones J., Shune L., Boissel N., Bondanza A., Mariconti L., Marchal A.-L., Quinn D.S., Yang J., Price A., Sohoni A., Treanor L.M., Orlando E.J., Mataraza J., Davis J., Lu D., Zhu X., Engels B., Moutouh-de Parseval L., Brogdon J.L., Moschetta M., Flinn I.W.. A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development. Cancer Discovery. 2023; 13(9)DOI:10.1158/2159-8290.CD-22-1276. PMID:37249512. IF:30.600(Q1/1D).

01/01/2023 Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: A survey-based study

Solano C., Castro-Rebollo P., Pérez-Martínez A., López-Corral L., Barba-Suñol P., Kwon M., Ortiz V., Sanz-Caballer J., Caballero A.C., Martínez J., Cedillo Á., Sureda A.. Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: A survey-based study. BMJ Open. 2023; 13(7)DOI:10.1136/bmjopen-2022-071371. PMID:37491085. IF:2.400(Q1/3D).

01/01/2023 A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts

Muñoz A., Ay C., Grilz E., López S., Font C., Pachón V., Castellón V., Martínez-Marín V., Salgado M., Martínez E., Calzas J., Ortega L., Rupérez A., Salas E., Pabinger I., Soria J.M.. A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts. JOURNAL OF CLINICAL ONCOLOGY. 2023; 41(16)DOI:10.1200/JCO.22.00255. PMID:36730884. IF:42.100(Q1/1D).

01/01/2023 Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies

García-Calderón C.B., Sierro-Martínez B., García-Guerrero E., Sanoja-Flores L., Muñoz-García R., Ruiz-Maldonado V., Jimenez-Leon M.R., Delgado-Serrano J., Molinos-Quintana Á., Guijarro-Albaladejo B., Carrasco-Brocal I., Lucena J.-M., García-Lozano J.-R., Blázquez-Goñi C., Reguera-Ortega J.L., González-Escribano M.-F., Reinoso-Segura M., Briones J., Pérez-Simón J.A., Caballero-Velázquez T.. Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1152498. PMID:37122702. IF:5.700(Q1/3D).

01/01/2023 Evolution of quality indicators in acute stroke during the RACECAT Trial: Impact in the general population

Olive-Gadea, M, de la Ossa, NP, Jovin, T, Abilleira, S, Jimenez, X, Cardona, P, Chamorro, A, Flores, A, Silva, Y, Purroy, F, Marti-Fabregas, J, Rodriguez-Campello, A, Zaragoza, J, Krupinski, J, Canovas, D, Choco, MG, Mas, N, Palomeras, E, Cocho, D, Aragones, JM, Repullo, C, Sanjurjo, E, Carrion, D, Catena, E, Costa, X, Almendros, MC, Barcelo, M, Monedero, J, Rybyeva, M, Diaz, G, Ribo, M. Evolution of quality indicators in acute stroke during the RACECAT Trial: Impact in the general population. International Journal of Stroke. 2023; 18(2)DOI:10.1177/17474930221093523. PMID:35373657. IF:6.300(Q1/1D).

01/01/2023 First pass effect in posterior circulation occlusions: Analysis from the CICAT registry

Terceno, M, Silva, Y, Bashir, S, Chamorro, A, de la Ossa, NP, Hernandez-Perez, M, Castano, C, Camps-Renom, P, Wenger, D, Cardona, P, Molina, C, Rodriguez-Campello, A, Canovas, D, Purroy, F, Salvat-Plana, M, Serena, J. First pass effect in posterior circulation occlusions: Analysis from the CICAT registry. International Journal of Stroke. 2023; 18(2)DOI:10.1177/17474930221089772. PMID:35272563. IF:6.300(Q1/1D).

01/01/2023 Presence of Ceramidase Activity in Electronegative LDL

Puig N., Rives J., Estruch M., Aguilera-Simon A., Rotllan N., Camacho M., Colomé N., Canals F., Sánchez-Quesada J.L., Benitez S.. Presence of Ceramidase Activity in Electronegative LDL. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(1)DOI:10.3390/ijms24010165. PMID:36613609. IF:4.900(Q1/3D).

01/01/2023 Exposure to secondhand aerosol from electronic cigarettes at homes: A real-life study in four European countries

Amalia B., Fu M., Tigova O., Ballbè M., Paniello-Castillo B., Castellano Y., Vyzikidou V.K., O'Donnell R., Dobson R., Lugo A., Veronese C., Pérez-Ortuño R., Pascual J.A., Cortés N., Gil F., Olmedo P., Soriano J.B., Boffi R., Ruprecht A., Ancochea J., López M.J., Gallus S., Vardavas C., Semple S., Fernández E.. Exposure to secondhand aerosol from electronic cigarettes at homes: A real-life study in four European countries. The Science of the total environment. 2023; 854DOI:10.1016/j.scitotenv.2022.158668. PMID:36099951. IF:8.200(Q1/1D).

01/01/2023 Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma

Castillo J.A., Plaza V., Rodrigo G., Juliá B., Picado C., Fernández C., Mullol J.. Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma. Journal Of Allergy And Clinical Immunology: Global. 2023; 2(4)DOI:10.1016/j.jacig.2023.100134. PMID:37781668. IF:(Q/D).

01/01/2023 Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review

Corominas H., Young D., Cummings J.R.F., Bouhnik Y., Armuzzi A., Thaci D., Kim J.. Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review. CLINICAL DRUG INVESTIGATION. 2023; 43(8)DOI:10.1007/s40261-023-01284-5. PMID:37615857. IF:(Q/D).

01/01/2023 Impact of Early Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A multicenter Randomized Controlled Trial

Sarasate M., González N., Córdoba-Izquierdo A., Prats E., Gonzalez-Moro, JMR, Martí S., Lujan M., Calle M., Antón A., Povedano M., Farrero E.. Impact of Early Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A multicenter Randomized Controlled Trial. Journal Of Neuromuscular Diseases. 2023; 10(4)DOI:10.3233/JND-221658. PMID:37212068. IF:3.200(Q2/3D).

01/01/2023 A crowdsourcing database for the copy-number variation of the Spanish population

López-López D., Roldán G., Fernández-Rueda J.L., Bostelmann G., Carmona R., Aquino V., Perez-Florido J., Ortuño F., Pita G., Núñez-Torres R., González-Neira A., Alonso A., Salgado-Garrido J., Pasalodos-Sanchez S., Ayuso C., Minguez P., Avila-Fernandez A., Corton M., Artuch R., Borrego S., Antiñolo G., Carracedo A., Amigo J., Castaño L.A., Tejada I., Delmiro A., Espinos C., Grinberg D., Guillén E., Lapunzina P., Lopez-Escámez J.A., Gallego-Martinez A., Martí R., Rovira E., Millán J.M., Moreno M.A., Morin M., Moreno-Galdó A., Fernández-Cancio M., Morte B., Mulero V., García D., Nunes V., Palau F., Perez B., Jurado L.P., Perona R., Pujol A., Ramos F., Lopez E., Ribes A., Rosell J., Surrallés J., Peña-Chilet M., Dopazo J.. A crowdsourcing database for the copy-number variation of the Spanish population. Human Genomics. 2023; 17(1)DOI:10.1186/s40246-023-00466-8. PMID:36894999. IF:3.800(Q2/3D).

01/01/2023 BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors

Bertran-Alamillo J., Giménez-Capitán A., Román R., Talbot S., Whiteley R., Floc’h N., Martínez-Pérez E., Martin M.J., Smith P.D., Sullivan I., Terp M.G., Saeh J., Marino-Buslje C., Fabbri G., Guo G., Xu M., Tornador C., Aguilar-Hernández A., Reguart N., Ditzel H.J., Martínez-Bueno A., Nabau-Moretó N., Gascó A., Rosell R., Pease J.E., Polanska U.M., Travers J., Urosevic J., Molina-Vila M.A.. BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors. Molecular Cancer. 2023; 22(1)DOI:10.1186/s12943-023-01815-w. PMID:37443114. IF:27.700(Q1/1D).

01/01/2023 Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes

Blanco R., Dómine M., González J.L., Loutfi S., Alfaro J., Saldaña J., Rubio J., Campos B., Hidalgo J., Barba A., Márquez D., Martin M., Olaverri A., Nadal E.. Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes. LUNG CANCER. 2023; 183DOI:10.1016/j.lungcan.2023.107318. PMID:37557022. IF:4.500(Q1/2D).

01/01/2023 Atezolizumab Plus Bevacizumab as First-line Treatment for Patients with Metastatic Nonsquamous Non-Small Cell Lung Cancer with High Tumor Mutation Burden: A Nonrandomized Controlled Trial

Provencio M., Ortega A.L., Coves-Sarto J., Calvo V., Marsé-Fabregat R., Dómine M., Guirado M., Carcereny E., Fernández N., Álvarez R., Blanco R., León-Mateos L., Sánchez-Torres J.M., Sullivan I.G., Cobo M., Sánchez-Hernández A., Massuti B., Sierra-Rodero B., Mártinez-Toledo C., Serna-Blasco R., Romero A., Cruz-Bermúdez A.. Atezolizumab Plus Bevacizumab as First-line Treatment for Patients with Metastatic Nonsquamous Non-Small Cell Lung Cancer with High Tumor Mutation Burden: A Nonrandomized Controlled Trial. JAMA Oncology. 2023; 9(3)DOI:10.1001/jamaoncol.2022.5959. PMID:36520426. IF:22.300(Q1/1D).

01/01/2023 Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations

Suárez-Calvet X., Fernández-Simón E., Natera D., Jou C., Pinol-Jurado P., Villalobos E., Ortez C., Monceau A., Schiava M., Codina A., Verdu-Díaz J., Clark J., Laidler Z., Mehra P., Gokul-Nath R., Alonso-Perez J., Marini-Bettolo C., Tasca G., Straub V., Guglieri M., Nascimento A., Diaz-Manera J.. Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations. Cell Death & Disease. 2023; 14(9)DOI:10.1038/s41419-023-06103-5. PMID:37673877. IF:8.100(Q1/2D).

01/01/2023 Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease

Mackenbach M.J., Willemse E.A.J., Van Den Dorpel J.J.A., Van Der Beek N.A.M.E., Díaz-Manera J., Rizopoulos D., Teunissen C., Van Der Ploeg A.T., Van Den Hout J.M.P.. Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease. NEUROLOGY. 2023; 101(6)DOI:10.1212/WNL.0000000000207482. PMID:37336766. IF:8.400(Q1/1D).

01/01/2023 Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies

Collet R., Caballero-Ávila M., Querol L.. Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies. REVUE NEUROLOGIQUE. 2023; 179(8)DOI:10.1016/j.neurol.2023.02.064. PMID:36907709. IF:2.800(Q2/4D).

01/01/2023 Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/ Dependency) Classification Correlates with Disease Severity and Quality of Life

Santos-Garcia, D, Fonticoba, TD, Bartolome, CC, Painceiras, MJF, Iniguez-Alvarado, MC, Diaz, IG, Jesus, S, Buongiorno, MT, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Sotos, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Gonzalez, MM, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LML, McAfee, D, Calopa, M, Carrillo, F, Sevilla, FE, Freire-Alvarez, E, Esteban, JCG, Ramos, RG, Luquin, MRI, Martinez-Torres, I, Ignacio, AS, Martinez-Martin, P, Mir, P. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/ Dependency) Classification Correlates with Disease Severity and Quality of Life. Journal of Parkinsons Disease. 2023; 13(3)DOI:10.3233/JPD-225073. PMID:36911948. IF:4.000(Q2/3D).

01/01/2023 The success of assessing cortical microstructure through surface-based diffusion-weighted neuroimaging.

Sampedro F. The success of assessing cortical microstructure through surface-based diffusion-weighted neuroimaging.. CLINICAL NEUROLOGY AND NEUROSURGERY. 2023; 234DOI:10.1016/j.clineuro.2023.107990. PMID:37806052. IF:1.800(Q2/5D).

01/01/2023 Adult Aedes albopictus in winter: implications for mosquito surveillance in southern Europe

Lührsen D.S., Zavitsanou E., Cerecedo-Iglesias C., Pardo-Araujo M., Palmer J.R.B., Bartumeus F., Montalvo T., Michaelakis A., Lowe R.. Adult Aedes albopictus in winter: implications for mosquito surveillance in southern Europe. Lancet Planetary Health. 2023; 7(9)DOI:10.1016/S2542-5196(23)00170-5. PMID:37673540. IF:24.200(Q1/1D).

01/01/2023 Effect of COVID-19 prevention as part of an urban renewal programme

Fernández-Barrés S., Perez G., Piñero M., Reyes A., Pérez K., Artazcoz L., Borrell C.. Effect of COVID-19 prevention as part of an urban renewal programme. PUBLIC HEALTH. 2023; 223DOI:10.1016/j.puhe.2023.07.014. PMID:37666182. IF:3.900(Q1/2D).

01/01/2023 Availability and costs of medicines for the treatment of tuberculosis in Europe

Günther G., Guglielmetti L., Leu C., Lange C., van Leth F., Hasan Hafizi, Khachatryan N., Aroyan H., Kabasakalyan E., Knappik M., Skrahina A., Klimuk D., Nikolenka A., Muylle I., Milanov V., Velkovska D., Tarinska N., Bachiyska E., Jankovic M., Pieridou D., Adamide T., Nicolaou N., Vasakova M., Sukholytka M., Kopeckà E., Folkvardsen D.B., Svensson E., Danilovits M., Kummik T., Vasankari T., Fréchet-Jachym M., Nahmiash A., Togonidze T., Avaliani Z., Kinkladze I., Aspindzelashvili R., Bichashvili T., Losaberidze G., Merabishvili T., Kalsdorf B., Manika K., Tsiakitzis K., Bakos A., Ægisdóttir T.R., Michelsen G.S., Karlsdóttir K., McLaughlin A.-M., Fitzgibbon M., Chemtob D., Codecasa L.R., Ferrarese M., Torri S., Gjocaj M., Kuksa L., Davidaviciene E., Wirtz G., Perrin M., Asciak A.P., Chesov D., de Lange W., Akkerman O., Poposka B.I., Mack U., Jensenius M., Kvalvik L., Mengshoel A.T., Kruczak K., Duarte R., Ribeiro N., Ibraim E., Kaluzhenina A., Barkanova O., Pesut D., Solovic I., Svetina P., Souza-Galvão M.-L.D., Millet J.-P., Casas X., Vives M., Bruchfeld J., Dalemo P., Jonsson J., Aeschbacher K., Keller P., Özkara S., Tiberi S., Chen C., Terleeva Y., Dudnyk A.. Availability and costs of medicines for the treatment of tuberculosis in Europe. CLINICAL MICROBIOLOGY AND INFECTION. 2023; 29(1)DOI:10.1016/j.cmi.2022.07.026. PMID:35961488. IF:10.900(Q1/1D).

01/01/2023 Digitalization and official food safety inspections at retail establishments

Grau-Noguer E., Suppi R., Rodríguez-Sanz M., Serratosa J., Bolao A., Lundén J., Hau P., Melo de Vasconcelos F., Åberg R., Blomgren C., Lambert M., Leppik K., Vågsholm I., Kautto A.H., Lueckl J., Abeln-Richter S., Kamphausen R., Bammens E., Georgiades F., Altenburgs J., Portaña S.. Digitalization and official food safety inspections at retail establishments. FOOD CONTROL. 2023; 154DOI:10.1016/j.foodcont.2023.109950. PMID:. IF:5.600(Q1/2D).

01/01/2023 Basic concepts for understanding and improving clinical appropriateness

Bonfill Cosp X.. Basic concepts for understanding and improving clinical appropriateness. Educacion Medica. 2023; 24(3)DOI:10.1016/j.edumed.2023.100813. PMID:. IF:(Q/D).

01/01/2023 Occupational health. Concepts and techniques for the prevention of occupational hazards

Cortes-Franch, I. Occupational health. Concepts and techniques for the prevention of occupational hazards. Gaceta Sanitaria. 2023; 37DOI:10.1016/j.gaceta.2022.102263. PMID:. IF:1.500(Q3/7D).

01/01/2023 Risk-of-bias assessment of the randomized clinical trials and systematic reviews on surgical treatments for breast cancer-related lymphedema: A mapping review

Al-Sakkaf A.M., Bonfill X., Ardiles-Ruesjas S., Bendersky-Kohan J., Sola I., Masia J.. Risk-of-bias assessment of the randomized clinical trials and systematic reviews on surgical treatments for breast cancer-related lymphedema: A mapping review. Journal of Plastic Reconstructive and Aesthetic Surgery. 2023; 84DOI:10.1016/j.bjps.2023.05.002. PMID:37329747. IF:2.000(Q2/4D).

01/01/2023 Strategy for the promotion of equitable and healthy relationships in educational centers in Barcelona

Pérez G., Bartroli M., Pasarín M.I., Artazcoz L., Juárez O.. Strategy for the promotion of equitable and healthy relationships in educational centers in Barcelona. Gaceta Sanitaria. 2023; 37DOI:10.1016/j.gaceta.2022.102286. PMID:36645958. IF:1.500(Q3/7D).

01/01/2023 Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map

Salazar J., Bracchiglione J., Acosta-Dighero R., Meza N., Meade A.-G., Quintana M.J., Requeijo C., Rodríguez-Grijalva G., Santero M., Selva A., Solà I., Bonfill X., Salas K., Antequera A., Auladell-Rispau A., Urrútia G., Meinardi P., Irassar J., Simancas D., Dorantes R., Merchán A., Cantero Y., Hernandez E., Sugrañes M.. Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map. SUPPORTIVE CARE IN CANCER. 2023; 31(2)DOI:10.1007/s00520-022-07564-8. PMID:36622453. IF:2.800(Q1/1D).

01/01/2023 RIRS with disposable or reusable scopes: does it make a difference? Results from the multicenter FLEXOR study

Gauhar V., Chai C.A., Chew B.H., Singh A., Castellani D., Tailly T., Emiliani E., Keat, WOL, Ragoori D., Lakmichi M.A., Teoh, JYC, Traxer O., Somani B.K.. RIRS with disposable or reusable scopes: does it make a difference? Results from the multicenter FLEXOR study. Therapeutic Advances in Urology. 2023; 15DOI:10.1177/17562872231158072. PMID:36923302. IF:2.600(Q2/4D).

01/01/2023 The future of robotic surgery in urology: from augmented reality to the advent of metaverse

Checcucci E., Verri P., Amparore D., Cacciamani G.E., Rivas J.G., Autorino R., Mottrie A., Breda A., Porpiglia F.. The future of robotic surgery in urology: from augmented reality to the advent of metaverse. Therapeutic Advances in Urology. 2023; 15DOI:10.1177/17562872231151853. PMID:36744045. IF:2.600(Q2/4D).

01/01/2023 Analysis of Complications After Robot-Assisted Radical Cystectomy Between 2002-2021

Houenstein H.A., Jing Z., Elsayed A.S., Ramahi Y.O., Stöckle M., Wijburg C., Hosseini A., Wiklund P., Kim E., Kaouk J., Dasgupta P., Khan M.S., Wagner A.A., Syed J.R., Peabody J.O., Badani K., Richstone L., Mottrie A., Maatman T.J., Balbay D., Redorta J.P., Rha K.H., Gaboardi F., Rouprêt M., Aboumohamed A., Hussein A.A., Guru K.A.. Analysis of Complications After Robot-Assisted Radical Cystectomy Between 2002-2021. UROLOGY. 2023; 171DOI:10.1016/j.urology.2022.08.049. PMID:36241062. IF:2.100(Q2/5D).

01/01/2023 Evaluation of the Effectiveness of Interventions on Nephrolithiasis in Transplanted Kidney

Boissier R., Rodriguez-Faba O., Zakri R.H., Hevia V., Budde K., Figueiredo A., García E.L., Olsburgh J., Regele H., Yuan C.Y., Breda A.. Evaluation of the Effectiveness of Interventions on Nephrolithiasis in Transplanted Kidney. European Urology Focus. 2023; 9(3)DOI:10.1016/j.euf.2022.11.019. PMID:36567234. IF:4.900(Q1/2D).

01/01/2023 Sclerotic Bone Lesions as a Clue in the Diagnosis of Three Generations of Tuberous Sclerosis Complex: Case Report and Review of Literature

Iznardo H., Bernal S., Boronat S., Roé E.. Sclerotic Bone Lesions as a Clue in the Diagnosis of Three Generations of Tuberous Sclerosis Complex: Case Report and Review of Literature. PEDIATRIC NEUROLOGY. 2023; 148DOI:10.1016/j.pediatrneurol.2023.07.022. PMID:37634327. IF:3.200(Q1/2D).

01/01/2023 The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training

Larcher A., Cei F., Belladelli F., Rosiello G., Andrea Bravi C., Fallara G., Basile G., Lucianò R., Karakiewicz P., Mottrie A., Breda A., Briganti A., Salonia A., Bertini R., Montorsi F., Capitanio U.. The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training. European Urology Open Science. 2023; 49DOI:10.1016/j.euros.2022.12.007. PMID:36874599. IF:3.200(Q1/2D).

01/01/2023 Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classifications in Dermatology

Puig L.. Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classifications in Dermatology. Actas Dermo-Sifiliograficas. 2023; 114(10)DOI:10.1016/j.ad.2023.07.013. PMID:37482290. IF:(Q/D).

01/01/2023 "Acute kidney injury in critically ill patients with COVID-19: The AKICOV multicenter study in Catalonia"

De La Vega Sánchez A., Pérez A.N., Pérez-Carrasco M., Sonet M.T., Buendia Y.D., Ballujera P.O., López M.R., Riera J.S., Olmo-Isasmendi A., Torra E.V., García-Pumarino M.A., Villamayor M.I., Ibars R.M.C., Zelaya I.O., Chica J.P., Anglès C.R., Tomasa-Irriguible T.M., Serra A.B., Casanova E.J., González De Molina F.J.. "Acute kidney injury in critically ill patients with COVID-19: The AKICOV multicenter study in Catalonia". PLoS One. 2023; 18(4)DOI:10.1371/journal.pone.0284248. PMID:37058544. IF:2.900(Q1/3D).

01/01/2023 Reply to: “Comment on ‘Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes’”

Schneller-Pavelescu L., Vergara-de Caso E., Martorell A., Romaní J., Lázaro M., Vilarrasa E., Díaz-Ley B., Vázquez-Osorio I., Segura Palacios J.M., Azaña J.M., González-López M.A., Cañueto J., Molina-Leyva A., Leiva-Salinas M., Navarro-Triviño F.J., Sánchez-Payá J., Pascual J.C.. Reply to: “Comment on ‘Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes’”. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2023; 88(5)DOI:10.1016/j.jaad.2019.03.006. PMID:30872153. IF:12.800(Q1/1D).

01/01/2023 Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study

Pallauf M., D'Andrea D., König F., Laukhtina E., Yanagisawa T., Rouprêt M., Daneshmand S., Djaladat H., Ghoreifi A., Soria F., Fujita K., Boorjian S.A., Potretzke A.M., Mari A., Roumiguié M., Antonelli A., Bianchi A., Khene Z.-E., Sfakianos J.P., Jamil M., Boormans J.L., Raman J.D., Grossmann N.C., Breda A., Heidenreich A., Del Giudice F., Singla N., Shariat S.F., Pradere B.. Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study. JOURNAL OF UROLOGY. 2023; 209(3)DOI:10.1097/JU.0000000000003085. PMID:36475808. IF:6.400(Q1/1D).

01/01/2023 Latitudes and attitudes: A multinational study of laparoscopic pyeloplasty in children

Echeverria P., Reed L F., Gatti J.M., Braga L.H., Cherian A., Garcia-Aparicio L., Metcalfe P., Ruiz J., Bortagaray J.I., Martin-Sole O., Leclair M.D., Bujons A., de Badiola F., Coleman R., Webb N.R., Corbetta J.P., Moldes J.M., Mushtaq I., Lopez P.-J.. Latitudes and attitudes: A multinational study of laparoscopic pyeloplasty in children. Journal of Pediatric Urology. 2023; 19(1)DOI:10.1016/j.jpurol.2022.10.005. PMID:36336623. IF:2.000(Q2/4D).

01/01/2023 Bimekizumab in the Treatment of Plaque Psoriasis Focus on Patient Selection and Perspectives

Camina-Conforto, G, Mateu-Arrom L., López-Ferrer A., Puig L.. Bimekizumab in the Treatment of Plaque Psoriasis Focus on Patient Selection and Perspectives. Patient Preference and Adherence. 2023; 17DOI:10.2147/PPA.S350760. PMID:37408843. IF:2.000(Q2/4D).

01/01/2023 PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries

Langenbruch A., Mohr N., Andrees V., Kessens I., Reich A., Czarnecka-Operacz M., Puig L., Dauden E., Iversen L., Augustin M.. PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries. ACTA DERMATO-VENEREOLOGICA. 2023; 103DOI:10.2340/actadv.v103.6532. PMID:37649411. IF:3.500(Q1/3D).

01/01/2023 Reply to Comments on the SENefro Consensus Document on Autosomal Dominant Polycystic Kidney Disease

Ortiz, A, Ars, E, Bernis, C, Fraga, G, Furlano, M, Martinez, V, Martins, J, Perez-Gomez, MV, Rodriguez-Perez, JC, Sans, L, Torra, R. Reply to Comments on the SENefro Consensus Document on Autosomal Dominant Polycystic Kidney Disease. NEFROLOGIA. 2023; 43(1)DOI:10.1016/j.nefro.2022.07.002. PMID:37217372. IF:2.000(Q2/5D).

01/01/2023 Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.

Pujade-Lauraine E, Brown J, Barnicle A, Wessen J, Lao-Sirieix P, Criscione SW, du Bois A, Lorusso D, Romero I, Petru E, Yoshida H, Vergote I, Colombo N, Hietanen S, Provansal M, Schmalfeldt B, Pignata S, Martín Lorente C, Berton D, Runnebaum IB, Ray-Coquard I. Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.. JCO Precision Oncology. 2023; 7DOI:10.1200/PO.22.00258. PMID:36716415. IF:5.300(Q1/2D).

01/01/2023 The polygenic basis of relapse after a first episode of schizophrenia

Segura À.-G., Prohens L., Gassó P., Rodríguez N., Garcia-Rizo C., Moreno-Izco L., Andreu-Bernabeu Á., Zorrilla I., Mane A., Rodriguez-Jimenez R., Roldán A., Sarró S., Ibáñez Á., Usall J., Sáiz P.A., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Bernardo M., Mas S., Mezquida G., Arbelo N., De Matteis M., Galvañ J., Duque Guerra A., Arias i Queralt L., Perez-Bacigalupe M., Gonzalez-Ortega I., Toll A., Casanovas F., Sanchez-Pastor L., Valtueña M., Pomarol-Clotet E., García-León M.Á., Butjosa A., Rubio-Abadal E., Ribeiro M., López-Ilundain J.M., Saiz-Ruiz J., León-Quismondo L., Rivero O., Ruiz P., Echevarría R.S., García-Portilla M.P.. The polygenic basis of relapse after a first episode of schizophrenia. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; 75DOI:10.1016/j.euroneuro.2023.06.003. PMID:37603902. IF:(Q/D).

01/01/2023 Diagnosis and treatment of primary thyroid lymphoma from a surgical perspective: a multi-institutional study

González-Sánchez C., Salvador-Egea M.P., Glückmann-Maldonado E., Ríos A., Martín-Fernández J., Pérez-García J.I., García-Lorenzo F., Flores-Pastor B., Gómez-Ramírez J., Ortega-Serrano J., Ros-López S., Villar-del-Moral J., Morales-García D., Gutiérrez-Rodríguez M.T., Domènech-Calvet J., Nuño-Vázquez-Garza J.M., Franch-Arcas G.. Diagnosis and treatment of primary thyroid lymphoma from a surgical perspective: a multi-institutional study. LANGENBECKS ARCHIVES OF SURGERY. 2023; 408(1)DOI:10.1007/s00423-023-02945-x. PMID:37221304. IF:2.100(Q2/4D).

01/01/2023 Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders

Segal A., Parkes L., Aquino K., Kia S.M., Wolfers T., Franke B., Hoogman M., Beckmann C.F., Westlye L.T., Andreassen O.A., Zalesky A., Harrison B.J., Davey C.G., Soriano-Mas C., Cardoner N., Tiego J., Yücel M., Braganza L., Suo C., Berk M., Cotton S., Bellgrove M.A., Marquand A.F., Fornito A.. Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders. NATURE NEUROSCIENCE. 2023; 26(9)DOI:10.1038/s41593-023-01404-6. PMID:37580620. IF:21.300(Q1/1D).

01/01/2023 Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease

Fortea, J, Garcia-Arcelay, E, Terrancle, A, Galvez, B, Diez-Carreras, V, Rebollo, P, Maurino, J, Garcia-Ribas, G. Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE. 2023; 93(1)DOI:10.3233/JAD-221160. PMID:36970902. IF:3.400(Q2/4D).

01/01/2023 Entering into 2.0 cystinuria management with a medical digital tool to monitor urine pH: A prospective, randomized study

Angerri O., Gracia S., Rousaud F., Kanashiro A., Emiliani E.. Entering into 2.0 cystinuria management with a medical digital tool to monitor urine pH: A prospective, randomized study. Actas Urologicas Espanolas. 2023; 47(9)DOI:10.1016/j.acuro.2023.02.004. PMID:. IF:(Q/D).

31/12/2022 GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases

Sala, R, Rioja-Blanco, E, Serna, N, Sanchez-Garcia, L, Alamo, P, Alba-Castellon, L, Casanova, I, Lopez-Pousa, A, Unzueta, U, Cespedes, MV, Vazquez, E, Villaverde, A, Mangues, R. GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases. DRUG DELIVERY. 2022; 29(1)DOI:10.1080/10717544.2022.2069302. PMID:35532120. IF:6.000(Q1/2D).

31/12/2022 An in-depth analysis of the sexuality needs of Barcelona's youth: a holistic view using mixed method

Forcadell-Diez, L, Benlliure, JB, Martinez, C, Perez, G. An in-depth analysis of the sexuality needs of Barcelona's youth: a holistic view using mixed method. Sexual and Reproductive Health Matters. 2022; 30(1)DOI:10.1080/26410397.2022.2135728. PMID:36399103. IF:6.000(Q1/1D).

31/12/2022 Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy

Domingo, P, Giralt, M, Gavalda-Navarro, A, Blasco-Roset, A, Delgado-Angles, A, Gallego-Escuredo, JM, Gutierrez, MD, Mateo, MG, Cereijo, R, Domingo, JC, Villarroya, F, Villarroya, J. Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophy. Adipocyte. 2022; 11(1)DOI:10.1080/21623945.2022.2042962. PMID:35300561. IF:3.300(Q3/6D).

30/12/2022 The Benefits of Early versus Late Therapeutic Intervention in Fabry Disease.

Furlano M, Ars E, Matamala A, Brossa V, Martí J, Del Prado-Venegas M, Crespi J, Roe E, Torra R. The Benefits of Early versus Late Therapeutic Intervention in Fabry Disease.. Case Reports In Genetics. 2022; 2022DOI:10.1155/2022/3208810. PMID:36619006. IF:(Q/D).

27/12/2022 Use of the Superblock model for promoting physical activity in Barcelona: a one-year observational comparative study

Puig-Ribera, A, Arumi-Prat, I, Cirera, E, Sola, M, Codina-Nadal, A, Palencia, L, Biaani, B, Perez, K. Use of the Superblock model for promoting physical activity in Barcelona: a one-year observational comparative study. Archives of Public Health. 2022; 80(1)DOI:10.1186/s13690-022-01005-y. PMID:36575474. IF:3.300(Q2/5D).